ACADEMIA

• Dementia Drugs See Modest Uptake in Japan amid Eligibility Limits, Safety Concerns
  April 9, 2026

• Cancer Drug Supply Risks Spur Calls for Pricing Reform: JSMO
  March 31, 2026

• Japan Ophthalmology Society Flags Off-Label Concerns Ahead of Upneeq Launch
  March 30, 2026

• Real-World Study Backs Lecanemab Safety, 90% Stay on Treatment
  March 25, 2026

• CAR-T Reimbursement Insufficient, Kyoto University Hospital Chief Warns
  March 11, 2026

• Japan Begins Investigator-Led PII of Padcev in Small Bowel Adenocarcinoma
  March 3, 2026

• 63% of OB-GYN Clinics Adopt RSV Maternal Vaccine 1 Year after Launch
  February 25, 2026

• Japan’s Maternal RSV Vaccine Uptake at 11.6%, Survey Finds
  January 15, 2026

• Early CGP Testing Cuts Mortality Risk by 41%, Research Shows
  December 1, 2025

• 5-Year Cancer Survival Shows Wide Gap by Tumor Types, Gains Seen in Lymphoma: NCC
  November 20, 2025

• Japan Sleep Society to Revise Insomnia Guidelines to Reflect Orexin Antagonists
  October 8, 2025

• Japan’s Sakaguchi Wins 2025 Nobel Prize in Medicine
  October 7, 2025

• Japanese Medical Societies Strongly Recommend COVID Vaccinations from October
  September 3, 2025

• Cardiologist Sees Promise in Airwin as First PAH Med to Tackle Disease Progression
  September 3, 2025

• Tohoku University Trial Finds Kidney Benefits for Constipation Drug Lubiprostone
  September 3, 2025

• Japan Hypertension Society to Release Revised Treatment Guidelines in August
  July 28, 2025

• Dust Mite Sublingual Immunotherapy Linked to Lower Antibiotic Use in Children
  July 25, 2025

• Japan Embraces New AML Era with Tibsovo Debut, Says Hematologist
  June 30, 2025

• Keytruda Label Update Unlocks First New Treatment in 14 Years for HER2-Positive Gastric Cancer: Oncologist
  June 24, 2025

• Oncologist Hails Amgen’s Imdelltra as “First New Option in 20 Years” for SCLC
  June 23, 2025

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »